SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: goldworldnet who wrote (314637)7/14/2009 10:47:59 AM
From: DMaA  Respond to of 793955
 
Patents, intellectual property rights is a gigantic and fascinating topic. So many conflicting aspects, so much about it I have never considered. Every time I read something about it I change my mind.



To: goldworldnet who wrote (314637)7/14/2009 10:50:11 AM
From: TideGlider  Read Replies (1) | Respond to of 793955
 
A lot of money goes into R&D, trials etc. More drugs fail than are approved. Without incentive to regain expenditures and some profit and the future of drugs are doomed.

You must also take into consideration that drugs compete with other drugs for every application and just as there may be no competition upon approval a new drug from a competitor can wipe out any hopes of profit or severely limit it. Than there are law suits etc...etc etc


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News